Sonic Healthcare Limited
SHL
Rankning i aktier
#2849
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Aktiekurs
$13.18
Marknadsvärde
$6.51B
Förändring (1 dag)
-0.21%
Förändring (1 år)
-5.73%
Land
AU
Handel Sonic Healthcare Limited (SHL)
Kategori
Healthcare
Intäkter för Sonic Healthcare Limited (SHL)
Intäkter i Jun 2026 TTM: $7.72B
Enligt Sonic Healthcare Limited senaste finansiella rapporter är företagets nuvarande intäkter (TTM) $7.72B. År 2024 hade företaget intäkter på $5.97B en ökning jämfört med intäkterna år 2023, som var $5.43B. Intäkter är det totala belopp som ett företag genererar från försäljning av varor eller tjänster. Till skillnad från vinst dras inga kostnader av.
Intäktshistorik för Sonic Healthcare Limited från 2000 till 2026
Intäkter vid slutet av varje år
| År | Intäkter | Ändra |
|---|---|---|
| 2026 (TTM) | $7.72B | 21.62% |
| 2025 | $6.35B | 6.44% |
| 2024 | $5.97B | 9.92% |
| 2023 | $5.43B | -15.46% |
| 2022 | $6.42B | -2.19% |
| 2021 | $6.56B | 44.93% |
| 2020 | $4.53B | 5.12% |
| 2019 | $4.31B | 6.21% |
| 2018 | $4.06B | 4.22% |
| 2017 | $3.89B | 5.59% |
| 2016 | $3.69B | 15.59% |
| 2015 | $3.19B | -12.32% |
| 2014 | $3.64B | 16.17% |
| 2013 | $3.13B | -7.83% |
| 2012 | $3.40B | 2.73% |
| 2011 | $3.31B | 31.31% |
| 2010 | $2.52B | 4.80% |
| 2009 | $2.40B | 7.41% |
| 2008 | $2.24B | 42.62% |
| 2007 | $1.57B | 29.80% |
| 2006 | $1.21B | 16.78% |
| 2005 | $1.03B | 45.21% |
| 2004 | $712.48M | 10.16% |
| 2003 | $646.79M | 35.18% |
| 2002 | $478.47M | 51.42% |
| 2001 | $315.99M | 0.00% |
| 2000 | 0.00 | 0.00% |
Intäkter för liknande företag eller konkurrenter
| Företag | Intäkter | Intäktsdifferens | Land |
|---|---|---|---|
| $46.34B | 499.99% |
US
|
|
| $25.11B | 225.10% |
US
|
|
| $2.71B | -64.95% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -4.54% |
US
|
